Offer - Urjas Oil for just ₹ 1 X
New Deletus P Syrup is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of New Deletus P Syrup safe for pregnant women?
Deletus P should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of New Deletus P Syrup safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Deletus P. It should only be taken after medical advice.
What is the effect of New Deletus P Syrup on the Kidneys?
Kidney can be affected by Deletus P. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of New Deletus P Syrup on the Liver?
Deletus P may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of New Deletus P Syrup on the Heart?
Side effects of Deletus P rarely affect the heart.
If you are suffering from any of the following diseases, you should not take New Deletus P Syrup unless your doctor advises you to do so -
Is this New Deletus P Syrup habit forming or addictive?
No, you will not get addicted to New Deletus P Syrup.
Interaction between Food and New Deletus P Syrup
Information is not available on the interaction of any foods with New Deletus P Syrup, due to a lack of research on this.
Interaction between Alcohol and New Deletus P Syrup
Due to lack of research, there is no information about the side effects of taking New Deletus P Syrup with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vazculep (phenylephrine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 135-136
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1020-1022
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219